Next-Gen Therapies
summary
Claims a working pipeline: automated microfluidic reprogramming with microscope Z‑stacking and gigapixel stitching, cloud annotation and AI that matches expert performance at colony selection, aiming to cut IPSC line turnaround from ~6–8 months to ~2–3 months and costs by a factor of 10. Also ships a CE‑marked metastasis detector with analysis times optimized to ≈6.5 minutes that makes pathologists on average 2.2× faster and is deployed in 26 UK hospitals.
AI-written summary · about
chapters (9)
- 0:00Next-gen therapies intro
- 1:24Regenerative medicine basics
- 8:13Stem cell therapy challenges
- 13:57AI for stem cell reprogramming
- 20:26AI cell colony evaluation
- 31:02AI in histopathology
- 35:57Deep learning for personalized med
- 41:23Future of regenerative med
- 44:16Q&A
related talks
21mFighting Cancer with AI
14mFrom Pixels to Pathways: Omni-Modal Cell Biology with AI
21mCreating Markets, Creating Trustworthiness: Standards for AI
10mGenesis Final Round - Drylab AI
20mTranslating a Trillion Pointo Diseases of Data into Therapies
39mSustainably Automate Manual Cell-Staining with Innovative Open-Sour...
22mReimaging Healthcare
42mHow Novel Compute Technology Transforms Life Science Research
